FOLH1 and prostate carcinoma: Prostate cancer cells express prostate-specific membrane antigen (PSMA), a Glu carboxypeptidase II, also called folate hydrolase-1, which hydrolyzes Glu from vitamin B9 (folic acid) and other substrates.